'You know I've joined your club. I'm the hot flush boy': A qualitative exploration of hot flushes and night sweats in men undergoing androgen deprivation therapy for prostate cancer

Psycho-Oncology

Volumn 22, Issue 12, 2013, Pages 2823-2830

  Eziefula, C U ^a   Grunfeld, E A ^b   Hunter, M S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

androgen deprivation therapy; cognitions; male flushes; oncology; prostate cancer; qualitative

Indexed keywords

ADJUSTMENT; ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CLINICAL ARTICLE; COPING BEHAVIOR; FATIGUE; HOT FLUSH; HUMAN; IMPOTENCE; INTIMACY; IRRITABILITY; MALE; MASCULINITY; MOOD CHANGE; NIGHT SWEAT; PERCEPTION; PHYSICAL ACTIVITY; POWERLESSNESS; PROSTATE CANCER; QUALITATIVE RESEARCH; SEMI STRUCTURED INTERVIEW; SEX ROLE; SEXUAL BEHAVIOR; SHAME; SLEEP DISORDER; SOCIAL ASPECT; WEIGHT GAIN;

ANDROGEN DEPRIVATION THERAPY; COGNITIONS; MALE FLUSHES; ONCOLOGY; PROSTATE CANCER; QUALITATIVE;

ADAPTATION, PSYCHOLOGICAL; AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANDROPAUSE; ANTINEOPLASTIC AGENTS, HORMONAL; HOT FLASHES; HUMANS; MALE; MASCULINITY; MIDDLE AGED; PROSTATIC NEOPLASMS; QUALITATIVE RESEARCH; SELF CONCEPT; SWEATING;

EID: 84890122799     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3355     Document Type: Article

References (49)

1. Office for National Statistics. Statistical bulletin: cancer incidence and mortality in the UK, 2007-2009, 2012, 1-22. Available: http://www.ons.gov. uk/ons/rel/cancer-unit/cancer-incidence-and-mortality/2007-2009/ stb-cancer-incidence-and-mortality.html. Accessed 17 Sep 2012.
2. National Collaborating Centre for Cancer (Great Britain). Prostate cancer: diagnosis and treatment: full guideline, February 2008. Cardiff: National Collaborating Centre for Cancer, 2008 Available: http://www.nice.org. uk/nicemedia/pdf/CG58FullGuideline.pdf
3. Schow DA, Renfer LG, Rozanski TA, Thompson IM,. Prevalence of hot flushes during and after neoadjuvant hormonal therapy for localized prostate cancer. South Med J 1998; 91: 855-857.
4. Sarosdy MF, Schellhammer PF, Soloway MS, et al,. Endocrine effects, efficacy and tolerability of a 10.8-mg depot formulation of goserelin acetate administered every 13 weeks to patients with advanced prostate cancer. BJU Int 1999; 83: 801-806.
5. Spetz AC, Hammar M, Lindberg B, Spångberg A, Varenhorst E,. Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation for metastatic carcinoma of the prostate. J Urol 2001; 166: 517-520.
6. Kronenberg F,. Hot flashes: phenomenology, quality of life, and search for treatment options. Exp Gerontol 1994; 29: 319-336.
7. Sievert LL, Obermeyer CM, Price K,. Determinants of hot flashes and night sweats. Ann Hum Biol 2006; 33: 4-16.
8. Woodward S, Freedman RR,. The thermoregulatory effects of menopausal hot flashes on sleep. Sleep 1994; 17: 497-501.
9. Mom CH, Buijs, C, Willemse PHB, Mourits MJE, de Vries EGE,. Hot flushes in breast cancer patients. Crit Rev Oncol Hematol 2006; 57: 63-77.
10. Deecher DC, Dorries K,. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages. Arch Womens Ment Health 2007; 10: 247-257.
11. Frisk J,. Managing hot flushes in men after prostate cancer - a systematic review. Maturitas 2010; 65: 15-22.
12. Spetz A-C, Zetterlund E-L, Varenhorst E, Hammar M,. Incidence and management of hot flashes in prostate cancer. J Support Oncol 2003; 1: 263-266, 269-270, 272-273; discussion 267-268, 271-272.
13. Dalal S, Zhukovsky DS,. Pathophysiology and management of hot flashes. J Support Oncol 2006; 4: 315-320, 325.
14. Nishiyama T, Kanazawa S, Watanabe R, Terunuma M, Takahashi K,. Influence of hot flashes on quality of life in patients with prostate cancer treated with androgen deprivation therapy. Int J Urol 2004; 11: 735-741.
15. Kagee A, Kruus LK, Malkowicz S, Vaughn DJ, Coyne JC,. The experience of hot flashes among prostate cancer patients receiving hormone treatment. Proceedings of the American Society of Clinical Oncology (abstr 2999) 2001; 20: abstr 2999.
16. Hunter MS, Ayers B, Smith M,. The Hot Flush Behavior Scale: a measure of behavioral reactions to menopausal hot flushes and night sweats. Menopause (New York, N.Y.) 2011; 18: 1178-1183.
17. Hunter MS, Mann E,. A cognitive model of menopausal hot flushes and night sweats. J Psychosom Res 2010; 69: 491-501.
18. Keefer L, Blanchard EB,. A behavioral group treatment program for menopausal hot flashes: results of a pilot study. Appl Psychophysiol Biofeedback 2005; 30: 21-30.
19. Swartzman LC, Edelberg R, Kemmann E,. Impact of stress on objectively recorded menopausal hot flushes and on flush report bias. Health Psychol 1990; 9: 529-545.
20. Hunter MS, Liao KL-M,. A psychological analysis of menopausal hot flushes. Br J Clin Psychol 1995; 34: 589-599.
21. Reynolds F,. Psychological responses to menopausal hot flushes: implications of a qualitative study for counselling interventions. Counsell Psychol Q 1997; 10: 309-321.
22. Reynolds F,. Relationships between catastrophic thoughts, perceived control and distress during menopausal hot flushes: exploring the correlates of a questionnaire measure. Maturitas 2000; 36: 113-122.
23. Rendall MJ, Simonds LM, Hunter MS,. The Hot Flush Beliefs Scale: a tool for assessing thoughts and beliefs associated with the experience of menopausal hot flushes and night sweats. Maturitas 2008; 60: 158-169.
24. Hunter MS, Coventry S, Mendes N, Grunfeld EA,. Menopausal symptoms following breast cancer treatment: a qualitative investigation of cognitive and behavioural responses. Maturitas 2009; 63: 336-340.
25. Ayers B, Smith M, Hellier J, Mann E, Hunter MS,. Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial. Menopause 2012; 19: 749-759.
26. Mann E, Smith MJ, Hellier J, et al,. Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial. Lancet Oncol 2012; 13: 309-318.
27. Coyne J, Vaughn DJ, Dinges D, Malkowicz SB, Gooneratne NS,. Hot flashes among prostate cancer patients undergoing androgen deprivation therapy: psychosocial and quality of life issues. U.S. Army Medical Research and Materiel Command 2006: 17.
28. Grunfeld EA, Halliday A, Martin P, Drudge-Coates L,. Andropause syndrome in men treated for metastatic prostate cancer: a qualitative study of the impact of symptoms. Cancer Nurs 2012; 35: 63-69.
29. Pope C, Mays N,. Qualitative research: reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ 1995; 311: 42-45.
30. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR). American Psychiatric Association: Washington DC, 2000.
31. Padesky CA,. Schema change processes in cognitive therapy. Clin Psychol Psychother 1994; 1: 267-278.
32. Ritchie J, Spencer L,. Qualitative data analysis for applied policy research. In:, Bryman A, Burgess RG, (eds). Analyzing Qualitative Data. Routledge: London; New York, 1994, 173-194.
33. Pope C, Ziebland S, Mays N,. Qualitative research in health care. Analysing qualitative data. BMJ (Clinical Research Ed.) 2000; 320: 114-116.
34. Malterud K,. Qualitative research: standards, challenges, and guidelines. Lancet 2001; 358: 483-488.
35. Leventhal H, Diefenbach M, Leventhal EA,. Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cognit Ther Res 1992; 16: 143-163.
36. Diefenbach MA, Leventhal H,. The common-sense model of illness representation: theoretical and practical considerations. J Social Distress Homeless 1996; 5: 11-38.
37. Chapple A, Ziebland S,. Prostate cancer: embodied experience and perceptions of masculinity. Sociology Health Illness 2002; 24: 820-841.
38. Grunfeld EA, Drudge-Coates L, Rixon L, Eaton E, Cooper AF,. Work behaviour following prostate cancer treatment: the role of beliefs about masculinity and disclosure. Health Psychol, in press.
39. Watson J,. Male Bodies: Health, Culture, and Identity. Open University Press: Buckinghamâ€̄; Philadelphia, Pa, 2000.
40. Courtenay WH,. Constructions of masculinity and their influence on men's well-being: a theory of gender and health. Soc Sci Med 2000; 50: 1385-1401.
41. Oliffe J,. Embodied masculinity and androgen deprivation therapy. Sociol Health Illn 2006; 28: 410-432. doi: 10.1111/j.1467-9566.2006.00499.x.
42. Wassersug RJ,. Mastering emasculation. J Clin Oncol 2008; 27: 634-636.
43. Strandmark MK,. Ill health is powerlessness: a phenomenological study about worthlessness, limitations and suffering. Scand J Caring Sci 2004; 18: 135-144.
44. Navon L, Morag A,. Advanced prostate cancer patients' ways of coping with the hormonal therapy's effect on body, sexuality, and spousal ties. Qual Health Res 2003; 13: 1378-1392.
45. Knobf MT,. The menopausal symptom experience in young mid-life women with breast cancer. Cancer Nurs 2001; 24: 201-210; quiz 210-211.
46. Walker LM, Tran S, Wassersug RJ, Thomas B, Robinson JW,. Patients and partners lack knowledge of androgen deprivation therapy side effects. Urol Oncol Semin Original Invest 2012; Jan 25 [Epub ahead of print]. doi: 10.1016/j.urolonc.2011.12.015
47. Smith JA, Osborn M,. Interpretative phenomenological analysis. In:, Breakwell GM, (ed.) Doing Social Psychology Research. The British Psychological Society and Blackwell Publishing Ltd.: Oxford, UK, 2008, 229-254.
48. Todres L,. Embodied enquiry: phenomenological touchstones for research, psychotherapy, and spirituality. Palgrave Macmillan: Houndmills, Basingstoke, Hampshireâ€̄; New York, 2007.
49. Todres L, Galvin, KT,. Embodied interpretation: a novel way of evocatively re-presenting meanings in phenomenological research. Qualitative Res 2008; 8: 568-583.